Overviews of the Drug Distribution System & Barriers to Opioid Availability Dr. Bishnu Dutta Paudel International Pain Policy Fellowship Training Program.

Slides:



Advertisements
Similar presentations
THE CHALLENGES & OPORTUNITIES OF ACCESS TO MEDICINES IN AFRICA Dr Pascoal MOCUMBI, orig Mozambique,High Representative EDCTP ABRASCO/WFPHA.
Advertisements

Our role in the U.S. pharmaceutical supply chain:
The international collaborative project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin.
Vienna, Austria 4 September 2014 Stefano Berterame, Chief Narcotics Control and Estimates Section Secretariat of the International Narcotics Control Board.
MeTa, Solwezi 27 August,2013.  A branded- name drug product is originally discovered and developed by a pharmaceutical company.  Branded-name drugs.
Nepal Case Study International Pain Policy Fellowship Training Program Madison, Wisconsin, USA 6 August 2012 Bishnu D. Paudel, MD Nepal.
Country Report for: ALBANIA DR. KRISTO HUTA. 2 Demographic Dat a Albania: Population Albania: Population »Year 1990: inhabitants. »Year 1990:
Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.
1 Potential & Actual Opioid Diversion in Vietnam, Methods of Preventing Diversion, and Barriers to “Balance” Eric Krakauer, MD, PhD Harvard Medical School.
Yuki Takao IGHI Student Challenges Competition 2013 – 27 th November Supervisor: Prof. Mark Thursz BARRIERS TO END OF LIFE CARE IN THE GAMBIA: How can.
PSK Annual Conference 2008 Palliative care medicine: A balanced approach to opioid availability and safe use in Kenya Presenter: Dr. Bilha Kiama-Murage.
You can use morphine Module 10. Learning objectives n Explain the place of morphine in the World Health Organization pain ladder. n Describe the side.
Action Plan India Priya, Nandini, Shalini, Dr. Sudhir, Rajesh, Raj, Frank, David.
The Estimation of National Opioid Requirements: New INCB/WHO Guidelines International Pain Policy Fellowship Training Session Madison, Wisconsin, USA 8.
Matching Interventions to Barriers in Pain Management Ruth Cornish Program Manager.
Towards an Integrity Standard in the Pharmaceutical Industry IACC Conference, May 27, 2003 Seoul, Korea Dr. Jillian Clare Cohen Assistant Professor, Leslie.
Perspectives of Former International Pain Policy Fellows International Pain Policy Fellowship Training Program Madison, Wisconsin, USA 6 August 2012 Bishnu.
The International Pain Policy Fellowship: Improving Opioid Availability and Access SUPPORT: Lance Armstrong Foundation Open Society Foundations, International.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
Situation analysis in Kyrgyzstan Making Opioids Available in Eastern Europe and Central Asia March 5-6, 2013 Vienna.
Maryland Cancer Plan Pain Management Committee Suzanne A Nesbit, PharmD, BCPS Clinical Coordinator, Cancer Pain Service Sidney Kimmel Comprehensive Cancer.
Opioid Workshop on National Drug Control Policy: “Opioids – the foundation of pain treatment” Translating barriers into Action WORKING WITH GOVERNMENT.
Primary Palliative Care - Challenges and Resources. The Case of Switzerland Vanessa Alvarado & Brigitte Liebig University of Applied Sciences Northwestern.
Scope of Practice and Licensure
Research Activities to Document Progress During IPPF Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist Pain & Policy Studies Group.
DON’T FORGET THE ‘E’ IN “MORPHINE” International Pain Policy Fellowship: Advocacy & Communications.
Designing a drug control system that balances access with prevention and control of misuse: What should it look like? Martha Maurer, MSSW, MPH, PhD Pain.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Country Report for: UKRAINE Natallia Datsiuk, MPH Bogomolets National Medical University Ukraine, Kyiv.
Understanding and Using INCB Opioid Consumption Statistics: Including Morphine Equivalence 8 August 2012 Martha Maurer, MSW, MPH, PhD Pain & Policy Studies.
DEVELOPMENT AND STANDARDS OF PALLIATIVE CARE IN HUNGARY Hungarian Hospice Foundation Dr. Katalin Muszbek.
“Improving opioid availability through advocacy” Experience from Serbia Snežana Bošnjak International Pain Policy Fellow ( ) Institute for Oncology.
WHO Access to Controlled Medications Programme & Ensuring balance in national policies on controlled substances Barbara Milani, Technical Officer Department.
Tanzania1. 2 Tanzania Assessment Gabriel Upunda Tanzania3 DemographicsTanzania Area (sq km)945,100 Population 32,900,000 25% urban GNP per capitaUS $240.
Global Access to Pain Relief Initiative (GAPRI) Meg O’Brien 1 Market Forecast in Eastern Europe and Central Asia March 2013.
Palliative Care: a Key Component of Care
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Country Report for:
Medicines and Service Availability and Accessibility in Cancer Care in Georgia 28 th August 2012 Tbilisi Tamari Rukhadze MD. PhD. Oncologist, International.
UICC WORLD CONGRESS: UICC WORLD CANCER CONGRESS 2006 JULY 8-12 TH, WASHINGTON, D.C. WORKING WITH GOVERNMENT AND NURSING TO EXTEND PAIN RELIEF TO THE PERIPHERY.
ACCESS TO MEDICINES - POLICY AND ISSUES
Institut Català d’Oncologia ICO DiR. The ‘Qualy’ End of Life Care Observatory - WHO Collaborating Centre for Public Health Palliative Care Programmes Central.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Methods to Evaluate and Improve National Policy: Focus on 2011 WHO Guidelines and PPSG Global Policy Evaluation Aaron M. Gilson, MS, MSSW, PhD Research.
Meg O’Brien, Ph.D. Director, Global Access to Pain Relief Initiative Procurement & Manufacture of IR Oral Morphine: Uganda experience 1.
“” “Balance” Jim Cleary, MD Associate Professor of Medicine Director, Palliative Care Medicine, UW Hospital & Clinics Director, WHO Collaborating Center.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
Global Challenges in Cancer Pain S. Lawrence Librach MD,CCFP,FCFP Professor, Department of Family & Community Medicine Sun Life Financial Chair & Director,
Development and Implementation of Good Pharmacy Practice Standards in Developing Countries Author: Frokjaer B, International Pharmaceutical Federation.
Ensuring Availability and Preventing Diversion International Pain Policy Fellowship August 7, 2012 David E. Joranson University of Wisconsin Pain & Policy.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
PROVIDA’S IMPACT ON IMPROVING ACCESS TO AND USE OF ESSENTIAL DRUGS IN POOR COMMUNITIES IN PERU JOSEFA CASTRO, PHARMACIST JORGE SOLARI, PHYSICIAN SERVICIO.
"Perspectives of former International Pain Policy Fellows" Prof. Snežana Bošnjak, MD, PhD Institute for Oncology and Radiology of Serbia (IORS) Belgrade,
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Introduction to pain Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
Preventing drug diversion: Principles and concepts International Pain Policy Fellowship August 7, 2012 David E. Joranson Distinguished Scientist, Founder.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
دکترارتین کمالی ثابتی ( متخصص پزشکی قانونی ومسمومیتها )
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
ACCESS TO QUALITY MEDICINES IN THE REGION-COUNTERFEITING PROBLEMS
Legal and Regulatory Issues in Pain Management
XVI International AIDS Conference
Pharmacy Practices Provided by Dispensing Doctors in Zimbabwe
Federal Regulations requirements for opioid prescription course
Indispensable, adequately provided and not unduly restricted
Disposal of controlled substances
Background Cancers are among the leading causes of morbidity and mortality worldwide, responsible for 18.1 million new cases and 9.6 million deaths in.
Situation analysis in Kyrgyzstan
Presentation transcript:

Overviews of the Drug Distribution System & Barriers to Opioid Availability Dr. Bishnu Dutta Paudel International Pain Policy Fellowship Training Program Madison, Wisconsin, USA 6 August 2012

GLOBAL DISPARITIES In 2010, eight countries together accounted for 85% of global consumption of morphine.

Why is opioid use so low? INCB Survey of government drug control authorities 1995(65 countries) & 2007( 144 countries) By: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center, 2008 International Narcotics Control Board. (1996). Report of the International Narcotics Control Board for 1995: Availability of Opiates for Medical Needs. New York, NY: United Nations.

Why is opioid use so low?  Barriers to opioid availability: 1)Fear of addiction 2) Lack of training health care providers 3) Excessively restrictive laws and regulations 4) Fear of legal consequences

Why is opioid use so low? 5) Insufficient supply of opioids 6) Cost of opioids 7)Inadequate health care resources 8) Lack of national policy, guidelines

Why is opioid use so low?  2006 Survey of Health care workers, and hospice/PC staff in Asia, Africa and Latin America By: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center, 2008 Adams, V. (2007). Access to Pain Relief – an essential human right. Help the Hospices, Worldwide Palliative Care Alliance.

Why is opioid use so low?  Barriers to accessing oral morphine: 1)Excessively strict national drug laws and regulations; 2)Fear of addiction; 3)Poorly developed health care systems; 4)Lack of knowledge

Barriers to opioid availability 1) Opioid Regulatory Policy 2) Drug Distribution System 3) Cost of Opioid Analgesics 4) Knowledge & Attitudes

DRUG DISTRIBUTION SYSTEM The entire system of medication procurement and distribution for health care.

Opioid Analgesics Information Level 1: International Narcotics Control Board Level 4: Hospitals / Pharmacies / Hospice/ PC facilities Level 6: PATIENTS Level 2: National Competent Authority Level 3: Importers / Manufacturers / Distributors Level 5: Physicians / Pharmacists / Nurses

DRUG DISTRIBUTION SYSTEM BARRIERS Government has not made procurement arrangements for importation or domestic manufacture of opioids Delays in government decision-making Inadequate methods for assessing medical needs

DRUG DISTRIBUTION SYSTEM BARRIERS Pharmacies that stock opioid medications are inadequate in number, in geographical location (rural areas), and/or hours of operation No system to ensure the safe transport of medications from wholesale level to retail level LACK OF DEMAND / Not ordered within country

COST OF OPIOID ANALGESICS -More expensive opioid analgesics available - No reimbursement for pain management or palliative care in national policies

COST OF OPIOID ANALGESICS Lack of low-cost / generic oral opioid analgesics (powder to make into tablets or solution)

CONCLUSIONS Barriers to opioid availability and patient access can be found at different levels: 1) Opioid Regulatory Policy 2) Drug Distribution System 3) Cost of Opioid Analgesics 4) Knowledge & Attitudes -

CONCLUSIONS Barriers must be identified and addressed in order to improve opioid availability to achieve pain relief. The International Pain Policy Fellowship is designed to assist with this process. Consider the barriers in your country before working on your Action Plans.

THANK YOU !